On Mother’s Day 2026, the Trump administration took a significant step in reorienting federal reproductive health priorities with the launch of moms.gov. The portal, designed as a central hub for maternal and family resources, immediately drew scrutiny for its prominent integration of "pregnancy centers"—more commonly known as Crisis Pregnancy Centers (CPCs)—alongside established Federally Qualified Health Centers and federal investment guidance. This move represents the culmination of years of advocacy by anti-abortion organizations and signals a shift in how the federal government categorizes and funds non-medical, faith-based support facilities.
Main Facts: What Are Crisis Pregnancy Centers?
Crisis Pregnancy Centers emerged in the 1960s as a cornerstone of the anti-abortion movement. Their primary objective is to dissuade pregnant individuals from seeking abortion care, instead promoting parenting or adoption. As of 2025, the U.S. Government Accountability Office (GAO) estimated there were between 2,400 and 2,800 such facilities operating nationwide.
While CPCs often market themselves as medical clinics—offering pregnancy tests, limited STI screenings, and "non-diagnostic" ultrasounds—the vast majority lack the clinical oversight typical of legitimate healthcare facilities. They are overwhelmingly affiliated with three major national networks: Heartbeat International, the National Institute of Family and Life Advocates (NIFLA), and Care Net.
The services provided by these centers are frequently conditioned upon religious participation or attendance at counseling sessions. Critically, these facilities are not "covered entities" under the Health Insurance Portability and Accountability Act (HIPAA), meaning they are not legally required to adhere to federal medical privacy standards. This has created a "privacy blind spot" where sensitive patient data is collected without the stringent protections afforded to patients at traditional medical clinics.
Chronology: A Legal and Political Evolution
- 1960s–2010s: CPCs establish a national footprint, focusing on "co-locating" near reproductive health clinics to intercept patients.
- 2018 (NIFLA v. Becerra): The Supreme Court rules that a California law requiring CPCs to disclose their licensing status (or lack thereof) constitutes unconstitutional "compelled speech," setting a high bar for state regulation.
- 2022 (Post-Dobbs): The reversal of Roe v. Wade accelerates the opening of CPCs, particularly in the South and in states with strict gestational limits.
- 2024: A wave of litigation begins as state Attorneys General attempt to regulate deceptive advertising practices regarding "abortion pill reversal" and data privacy.
- 2025–2026: States like Kansas, Montana, Oklahoma, and Wyoming pass "CARE Acts" (Center Autonomy and Right of Expression), shielding CPCs from state oversight.
- July 2026: The Trump administration releases a Title X Notice of Funding Opportunity (NOFO) that prioritizes "behavioral and lifestyle" approaches to health, effectively creating a pathway for CPCs to compete for federal family planning grants.
Supporting Data: The Funding and Infrastructure Gap
The financial scale of the CPC industry is substantial. In 2024 alone, it is estimated that these centers received over $2 billion in revenue, primarily through private donations, national network support, and state-level government allocations. Between 2022 and 2025, at least twenty-one states funneled $491 million in taxpayer dollars to these centers, even as hospital labor and delivery units continue to close in rural areas, creating "maternity care deserts."
Despite this influx of capital, CPCs have struggled to fill the void left by departing OB-GYN practitioners. A telling example occurred at the 7B Care Clinic in Idaho, which attempted to provide prenatal services following a local hospital closure. The effort collapsed when the center mandated that all contracted clinicians sign a "faith-based pledge," a requirement that led local medical professionals to resign, effectively preventing the center from expanding its clinical capacity.
Data from the American Journal of Public Health (2025) underscores the limited scope of medical services:
- 71% of CPCs offer non-diagnostic ultrasounds.
- 28% advertise STI testing.
- 6% advertise HIV testing.
Official Responses and Litigation
The expansion of federal and state support for CPCs has been met with a flurry of legal challenges. The administration’s 2027 Title X funding criteria—which emphasizes "fertility-awareness" and "body literacy" over traditional contraception—has been challenged by a coalition of 23 states and reproductive health organizations. These plaintiffs argue that the criteria are politically motivated and deviate from the statutory intent of the Title X program, which is designed to provide comprehensive, evidence-based reproductive healthcare.
Meanwhile, in the courtroom, CPCs have successfully utilized First Amendment arguments to insulate themselves from investigation:
- Investigative Subpoenas: In First Choice v. Platkin (2026), the Supreme Court ruled that state attempts to compel the disclosure of donor and data-handling records from a CPC violated associational rights, making it significantly more difficult for states to audit these organizations.
- False Advertising: The case of California v. Heartbeat International remains a pivotal trial regarding the promotion of "abortion pill reversal." While this case has reached the trial stage, other similar efforts in New York have been stymied by Second Circuit rulings that protect the rights of CPCs to advertise these treatments as protected speech.
Implications: The Erosion of Patient Autonomy
The implications of the federal government’s alignment with the CPC model are far-reaching. By positioning non-medical, ideological centers as legitimate alternatives to comprehensive health providers, the administration is effectively blurring the line between clinical medical care and religious counseling.
1. The HIPAA Privacy Gap
Because CPCs are not HIPAA-covered entities, clients are vulnerable to data breaches without recourse. When Heartbeat International accidentally exposed the personal health data of clients in Louisiana, federal regulators determined they lacked the jurisdiction to penalize the organization because the center was not a "covered entity." This leaves millions of patients in a regulatory "no-man’s-land."
2. The Deception of Informed Consent
The American College of Obstetricians and Gynecologists (ACOG) has issued repeated warnings that CPCs undermine patient autonomy. By using non-diagnostic ultrasounds—which are often performed by volunteers without medical imaging licenses—as a tool for emotional persuasion rather than diagnostic assessment, these centers may delay critical care. Cases of missed ectopic pregnancies, which are life-threatening, have already led to class-action litigation, yet many states have passed legislation that complicates the enforcement of ultrasound licensing requirements.
3. The Future of Reproductive Health Policy
As moms.gov integrates these centers into the federal safety net, the distinction between evidence-based healthcare and ideological advocacy continues to diminish. The shift in Title X funding suggests that the federal government is moving toward a "behavioral-based" health model, which critics argue is a thinly veiled effort to divert public funds away from contraceptive-based family planning and toward organizations that advocate for specific social and religious outcomes.
Ultimately, the trend toward protecting CPCs through "CARE Act" legislation and judicial reliance on the First Amendment suggests that these centers will remain a permanent, and likely expanding, fixture in the American healthcare landscape. For patients, the result is a fragmented system where the standard of care, the protection of private health data, and the availability of objective medical information vary wildly depending on the facility chosen, with few regulatory mechanisms left to hold these organizations accountable for their practices.
About the Author
